Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/101285
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Elitok, Saban | - |
dc.contributor.author | Devarajan, Prasad | - |
dc.contributor.author | Bellomo, Rinaldo | - |
dc.contributor.author | Isermann, Berend | - |
dc.contributor.author | Haase, Michael | - |
dc.contributor.author | Haase-Fielitz, Anja | - |
dc.date.accessioned | 2023-03-06T13:18:42Z | - |
dc.date.available | 2023-03-06T13:18:42Z | - |
dc.date.issued | 2022 | - |
dc.date.submitted | 2022 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/103240 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/101285 | - |
dc.description.abstract | Background Acute kidney injury (AKI) subtypes combining kidney functional parameters and injury biomarkers may have prognostic value. We aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL)/hepcidin-25 ratio (urinary concentrations of NGAL divided by that of hepcidin-25) defined subtypes are of prognostic relevance in cardiac surgery patients. Methods We studied 198 higher-risk cardiac surgery patients. We allocated patients to four groups: Kidney Disease Improving Global Outcomes (KDIGO)-AKI-negative and NGAL/hepcidin-25 ratio-negative (no AKI), KDIGO AKI-negative and NGAL/hepcidin-25 ratio-positive (subclinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-negative (clinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-positive (combined AKI). Outcomes included in-hospital mortality (primary) and long-term mortality (secondary). Results We identified 127 (61.6%) patients with no AKI, 13 (6.6%) with subclinical, 40 (20.2%) with clinical and 18 (9.1%) with combined AKI. Subclinical AKI patients had a 23-fold greater in-hospital mortality than no AKI patients. For combined AKI vs. no AKI or clinical AKI, findings were stronger (odds ratios (ORs): 126 and 39, respectively). After adjusting for EuroScore, volume of intraoperative packed red blood cells, and aortic cross-clamp time, subclinical and combined AKI remained associated with greater in-hospital mortality than no AKI and clinical AKI (adjusted ORs: 28.118, 95% CI 1.465–539.703; 3.737, 95% CI 1.746–7.998). Cox proportional hazard models found a significant association of biomarker-informed AKI subtypes with long-term survival compared with no AKI (adjusted ORs: pooled subclinical and clinical AKI: 1.885, 95% CI 1.003–3.542; combined AKI: 1.792, 95% CI 1.367–2.350). Conclusions In the presence or absence of KDIGO clinical criteria for AKI, the urinary NGAL/hepcidin-25-ratio appears to detect prognostically relevant AKI subtypes. | eng |
dc.description.sponsorship | Projekt DEAL 2021 | - |
dc.language.iso | eng | - |
dc.relation.ispartof | https://www.springer.com/journal/40620 | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject | Cardiopulmonary bypass | eng |
dc.subject | Cardiorenal syndrome | eng |
dc.subject | NGAL/hepcidin-25 ratio | eng |
dc.subject | Subclinical AKI | eng |
dc.subject.ddc | 610.72 | - |
dc.title | NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery : a prospective observational study | eng |
dc.type | Article | - |
dc.identifier.urn | urn:nbn:de:gbv:ma9:1-1981185920-1032406 | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | Journal of nephrology | - |
local.bibliographicCitation.volume | 35 | - |
local.bibliographicCitation.issue | 2 | - |
local.bibliographicCitation.pagestart | 597 | - |
local.bibliographicCitation.pageend | 605 | - |
local.bibliographicCitation.publishername | Springer | - |
local.bibliographicCitation.publisherplace | Milano | - |
local.bibliographicCitation.doi | 10.1007/s40620-021-01063-5 | - |
local.openaccess | true | - |
dc.identifier.ppn | 1817718401 | - |
local.bibliographicCitation.year | 2022 | - |
cbs.sru.importDate | 2023-03-06T13:14:57Z | - |
local.bibliographicCitation | Enthalten in Journal of nephrology - Milano : Springer, 1996 | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Medizinische Fakultät (OA) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Elitok et al._NGAL-hepcidin-25_2022.pdf | Zweitveröffentlichung | 1.81 MB | Adobe PDF | View/Open |